Techniclone International Corp.: The Tustin biotechnology company...
- Share via
Techniclone International Corp.: The Tustin biotechnology company said net income for the fiscal year ended April 30 totaled $325,300, contrasted with a net loss of $6.9 million for the previous year.
Revenue grew to $3.1 million, which included $3 million in licensing agreements, from $7,400.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
